Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HYpofractionated, Dose-redistributed RAdiotherapy With Protons and Photons to Combat Radiation-induced Immunosuppression in Head and Neck Squamous Cell Carcinoma (HYDRA)

NCT05364411 is registered in ClinicalTrials.gov with Joris B.W. Elbers as lead sponsor.

NCT NCT05364411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05364411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HYpofractionated, Dose-redistributed RAdiotherapy With Protons and Photons to Combat Radiation-induced Immunosuppression in Head and Neck Squamous Cell Carcinoma (HYDRA)
Lead sponsor
Joris B.W. Elbers
Phase
Not applicable
Overall status
Unknown status
Start date
October 10, 2022
Completion date
June 1, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck squamous cell carcinoma, hypofractionation, immune system suppression, proton therapy, radiotherapy